PortfoliosLab logo

BioNTech SE (BNTX)

Equity · Currency in USD · Last updated Jun 18, 2022

Company Info

ISINUS09075V1026
CUSIP09075V102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$125.14
Year Range$124.60 - $441.38
EMA (50)$152.41
EMA (200)$200.20
Average Volume$1.23M
Market Capitalization$31.39B

BNTXShare Price Chart


Chart placeholderClick Calculate to get results

BNTXPerformance

The chart shows the growth of $10,000 invested in BioNTech SE on Oct 11, 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $89,043 for a total return of roughly 790.43%. All prices are adjusted for splits and dividends.


BNTX (BioNTech SE)
Benchmark (^GSPC)

BNTXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-20.65%-10.13%
YTD-50.82%-22.90%
6M-55.30%-21.29%
1Y-37.80%-12.99%
5Y125.67%8.68%
10Y125.67%8.68%

BNTXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BNTXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioNTech SE Sharpe ratio is -0.48. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


BNTX (BioNTech SE)
Benchmark (^GSPC)

BNTXDividend History

BioNTech SE granted a 1.69% dividend yield in the last twelve months. The annual payout for that period amounted to $2.11 per share.


PeriodTTM202120202019
Dividend$2.11$0.00$0.00$0.00

Dividend yield

1.69%0.00%0.00%0.00%

BNTXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BNTX (BioNTech SE)
Benchmark (^GSPC)

BNTXWorst Drawdowns

The table below shows the maximum drawdowns of the BioNTech SE. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioNTech SE is 71.77%, recorded on Mar 7, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-71.77%Aug 10, 2021145Mar 7, 2022
-58.07%Mar 19, 202019Apr 15, 202068Jul 22, 202087
-44.5%Jul 23, 202029Sep 1, 202048Nov 9, 202077
-37.07%Dec 11, 202014Dec 31, 202069Apr 13, 202183
-36.7%Jan 9, 202044Mar 12, 20203Mar 17, 202047
-22.91%Nov 11, 20205Nov 17, 20208Nov 30, 202013
-20.51%Dec 18, 20192Dec 19, 20198Jan 2, 202010
-20.25%Oct 23, 20194Oct 28, 201919Nov 22, 201923
-19.58%May 4, 20213May 6, 202118Jun 2, 202121
-15.59%Jun 10, 20215Jun 16, 202122Jul 19, 202127

BNTXVolatility Chart

Current BioNTech SE volatility is 63.71%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BNTX (BioNTech SE)
Benchmark (^GSPC)

Portfolios with BioNTech SE


Loading data...